Published in Chest on July 01, 2006
Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 4.83
A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial. Ann Intern Med (2012) 4.10
A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation. N Engl J Med (2016) 3.99
Detection of lung cancer by sensor array analyses of exhaled breath. Am J Respir Crit Care Med (2005) 2.94
Counterpoint: Are the CHEST guidelines global in coverage? No. Chest (2015) 2.88
Causes and circumstances of death in pulmonary arterial hypertension. Am J Respir Crit Care Med (2013) 2.64
Diffuse alveolar hemorrhage: diagnosing it and finding the cause. Cleve Clin J Med (2008) 2.62
Electromagnetic navigation diagnostic bronchoscopy: a prospective study. Am J Respir Crit Care Med (2006) 2.40
Just imagine: new paradigms for medical education. Acad Med (2013) 2.14
Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol (2005) 1.96
Prevalence and prognostic value of left ventricular diastolic dysfunction in idiopathic and heritable pulmonary arterial hypertension. Chest (2011) 1.75
Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. Am J Med (2009) 1.70
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63
alpha1-Antitrypsin augmentation therapy for PI*MZ heterozygotes: a cautionary note. Chest (2008) 1.60
The bronchopulmonary pathology of alpha-1 antitrypsin (AAT) deficiency: findings of the Death Review Committee of the national registry for individuals with Severe Deficiency of Alpha-1 Antitrypsin. Hum Pathol (2004) 1.55
A review of physician turnover: rates, causes, and consequences. Am J Med Qual (2004) 1.49
Exploring leadership competencies in established and aspiring physician leaders: an interview-based study. J Gen Intern Med (2008) 1.48
Laboratory evaluation of the Vortran Automatic Resuscitator Model RTM. Respir Care (2007) 1.41
A comparison of respiratory care workload with 2 different nebulizers. Respir Care (2009) 1.39
Use of noninvasive positive-pressure ventilation on the regular hospital ward: experience and correlates of success. Respir Care (2006) 1.39
Acute eosinophilic pneumonia complicating Coccidioides immitis pneumonia: a case report and literature review. Respiration (2007) 1.39
Respiratory care work assignment based on work rate instead of work load. Respir Care (2011) 1.39
Impact of a program to provide patients with comparative information about providers of durable medical equipment for home respiratory care. Respir Care (2004) 1.39
Changing patterns of inpatient respiratory care services over a decade at the Cleveland Clinic: challenges posed and proposed responses. Respir Care (2005) 1.38
A middle-aged woman with chronic liver disease and shortness of breath. Cleve Clin J Med (2006) 1.38
Severe agitation among ventilated medical intensive care unit patients: frequency, characteristics and outcomes. Intensive Care Med (2004) 1.32
Perspective: Can emotional intelligence training serve as an alternative approach to teaching professionalism to residents? Acad Med (2011) 1.30
Role of flexible bronchoscopy in immunocompromised patients with lung infiltrates. Chest (2004) 1.16
Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency. Thorax (2007) 1.12
Detection of upper airway obstruction with spirometry results and the flow-volume loop: a comparison of quantitative and visual inspection criteria. Respir Care (2009) 1.10
Frequency and impact of pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am J Cardiol (2009) 1.09
Pulmonary venous thrombosis and infarction complicating pulmonary venous stenosis following radiofrequency ablation. Respir Care (2004) 1.09
Leadership and organization development in health-care: lessons from the Cleveland Clinic. Adv Health Care Manag (2011) 1.09
Asthma features in severe alpha1-antitrypsin deficiency: experience of the National Heart, Lung, and Blood Institute Registry. Chest (2003) 1.09
IL10 polymorphisms are associated with airflow obstruction in severe alpha1-antitrypsin deficiency. Am J Respir Cell Mol Biol (2007) 1.08
The influence of mentorship and role modeling on developing physician-leaders: views of aspiring and established physician-leaders. J Gen Intern Med (2009) 1.08
Emphysema in nonsmokers: alpha 1-antitrypsin deficiency and other causes. Cleve Clin J Med (2002) 0.99
The utility of spirometry in diagnosing pulmonary restriction. Lung (2007) 0.98
An Official American Thoracic Society/American College of Chest Physicians Policy Statement: Implementation of Low-Dose Computed Tomography Lung Cancer Screening Programs in Clinical Practice. Am J Respir Crit Care Med (2015) 0.96
Pneumonia due to Cryptococcus neoformans in a patient receiving infliximab: possible zoonotic transmission from a pet cockatiel. Respir Care (2004) 0.95
Interpreting pulmonary function tests: recognize the pattern, and the diagnosis will follow. Cleve Clin J Med (2003) 0.95
A review of alpha-1 antitrypsin deficiency. Semin Respir Crit Care Med (2005) 0.94
Augmentation therapy in alpha-1 antitrypsin deficiency. Expert Opin Biol Ther (2008) 0.91
Commentary: Recommendations and remaining questions for health care leadership training programs. Acad Med (2013) 0.91
Low levels of nitric oxide and carbon monoxide in alpha 1-antitrypsin deficiency. J Appl Physiol (1985) (2002) 0.90
Presence and outcomes of kidney disease in patients with pulmonary hypertension. Clin J Am Soc Nephrol (2014) 0.90
Interstitial pneumonitis and alveolar hemorrhage complicating use of rituximab: case report and review of the literature. Respiration (2007) 0.90
Validation of a multiprotein plasma classifier to identify benign lung nodules. J Thorac Oncol (2015) 0.90
Smoking cessation. Respir Care (2003) 0.89
Pulmonary hypertension after liver transplantation in patients with antecedent hepatopulmonary syndrome: a report of 2 cases and review of the literature. Liver Transpl (2006) 0.89
Transudative chylothorax associated with sclerosing mesenteritis. Respir Care (2010) 0.88
Association of IREB2 and CHRNA3 polymorphisms with airflow obstruction in severe alpha-1 antitrypsin deficiency. Respir Res (2012) 0.88
A review of alpha-1 antitrypsin deficiency. COPD (2005) 0.88
Right-to-left anatomic shunt associated with a persistent left superior vena cava: the importance of injection site in demonstrating the shunt. Chest (2009) 0.87
Caring for VIPs: nine principles. Cleve Clin J Med (2011) 0.87
Discordant utility of ideal body weight and body mass index as predictors of mortality in lung transplant recipients. J Heart Lung Transplant (2005) 0.87
Transudative chylothorax: report of two cases and review of the literature. Lung (2005) 0.87
Long-term experience after transition from parenteral prostanoids to oral agents in patients with pulmonary hypertension. Respir Med (2008) 0.87
What's the control in studies measuring the effect of computer-aided detection (CAD) on observer performance? Acad Radiol (2010) 0.87
A systematic review of physician leadership and emotional intelligence. J Grad Med Educ (2014) 0.86
Risk factors for symptom onset in PI*Z alpha-1 antitrypsin deficiency. Int J Chron Obstruct Pulmon Dis (2006) 0.86
Impact of induction concurrent chemoradiotherapy on pulmonary function and postoperative acute respiratory complications in esophageal cancer. Chest (2005) 0.86
Cost-effectiveness analysis of augmentation therapy for severe alpha1-antitrypsin deficiency. Am J Respir Crit Care Med (2003) 0.85
Circulating polymers in α1-antitrypsin deficiency. Eur Respir J (2014) 0.85
Strengths and limitations of the six-minute-walk test: a model biomarker study in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2011) 0.85
Detection of alpha-1 antitrypsin deficiency: a review. Respir Med (2008) 0.85
Alternative modes of mechanical ventilation: a review for the hospitalist. Cleve Clin J Med (2009) 0.85
A review of augmentation therapy for alpha-1 antitrypsin deficiency. Expert Opin Biol Ther (2012) 0.84
Major components of the direct medical costs of alpha1-antitrypsin deficiency. Chest (2003) 0.84
Frequency and causes of combined obstruction and restriction identified in pulmonary function tests in adults. Respir Care (2010) 0.83
Serum free fatty acid biomarkers of lung cancer. Chest (2014) 0.83
Hemoptysis in a 77-year-old male with a systolic murmur. Chest (2005) 0.82
The prevalence of alpha-1 antitrypsin deficiency among patients found to have airflow obstruction. COPD (2012) 0.82
Knowledge of alpha-1 antitrypsin deficiency among internal medicine house officers and respiratory therapists: results of a survey. Respir Care (2010) 0.82
Acute renal failure and sepsis. N Engl J Med (2004) 0.81
Results of a survey of patients with alpha-1 antitrypsin deficiency. Respiration (2005) 0.81
Metaphorical medicine: using metaphors to enhance communication with patients who have pulmonary disease. Ann Intern Med (2002) 0.81
Myths and misconceptions about {alpha}1-antitrypsin deficiency. Arch Intern Med (2009) 0.81
Association of cigarette smoking and CRP levels with DNA methylation in α-1 antitrypsin deficiency. Epigenetics (2012) 0.81
Estimating FVC from FEV2 and FEV3: assessment of a surrogate spirometric parameter. Chest (2005) 0.80
Serum high-density lipoprotein cholesterol levels as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension. Am J Cardiol (2012) 0.80
Cost-effectiveness of population screening for alpha-1 antitrypsin deficiency: a decision analysis. COPD (2005) 0.80
Bias, underestimation of risk, and loss of statistical power in patient-level analyses of lesion detection. Eur Radiol (2009) 0.80
Pulmonary hypertension in lung diseases: survey of beliefs and practice patterns. Respir Med (2010) 0.80
Long-term outcome in a patient with pulmonary hypertension and hereditary hemorrhagic telangiectasia. Chest (2007) 0.80
Endobronchial hamartoma causing massive hemoptysis. J Bronchology Interv Pulmonol (2009) 0.80
Alpha-1 antitrypsin (AAT) deficiency - what are the treatment options? Expert Opin Pharmacother (2009) 0.79
High-pitch ECG-synchronized pulmonary CT angiography versus standard CT pulmonary angiography: a prospective randomized study. AJR Am J Roentgenol (2013) 0.79
Oxygen therapy in advanced COPD: in whom does it work? Semin Respir Crit Care Med (2010) 0.79
Augmentation therapy for alpha(1)-antitrypsin deficiency. Drugs (2004) 0.79
Alpha-1 antitrypsin deficiency: an under-recognized but important issue for respiratory therapists. Respir Care (2003) 0.79
A comparison of methohexital versus etomidate for endotracheal intubation of critically ill patients. Am J Crit Care (2010) 0.78
Give me a sign, any sign. Thorax (2009) 0.77
How many ways can we say that cigarette smoking is bad for you? Chest (2004) 0.77
Does noninvasive positive pressure ventilation have a role in managing hypercapnic respiratory failure due to an acute exacerbation of COPD? Cleve Clin J Med (2008) 0.77
A thirty-four-year-old woman with chronic dyspnea and pulmonary interlobular septal thickening. Erdheim-Chester Disease. Respiration (2013) 0.77
A review of the alpha-1 foundation: its formation, impact, and critical success factors. Respir Care (2006) 0.76